Electrostatic Interaction-Induced Aggregation-Induced Emission-Type AgAu Bimetallic Nanoclusters as a Highly Efficient Electrochemiluminescence Emitter for Ultrasensitive Detection of Glial Fibrillary Acidic Protein.
Xiaofeng WangXiaochun ZhuXiaoyu ShiYing ZhouYa-Qin ChaiRuo YuanPublished in: Analytical chemistry (2023)
Herein, the aggregation-induced emission (AIE)-type carboxymethyl chitosan (CMCS)@6-aza-2-thiothymine (ATT) templated AgAu bimetallic nanoclusters (CMCS@ATT-AgAu BMNCs) with superior electrochemiluminescence (ECL) emission were first synthesized to construct a biosensor for the ultrasensitive detection of glial fibrillary acidic protein (GFAP). Impressively, unlike the traditional AIE-type bimetallic nanoclusters (BMNCs) obtained by complicated multi-step synthesis, the AIE-type CMCS@ATT-AgAu BMNCs were prepared by the electrostatic interaction between the negatively charged ATT and positively charged CMCS, in which the molecule ATT was served as a capping and reducing agent of bimetal ions. In addition, a rapidly moving cholesterol labeled DNA walker was constructed to move freely on the lipid bilayer to increase its moving efficiency, and the well-regulated DNA was intelligently designed to further improve its walking efficiency for rapid and ultrasensitive detection of GFAP with a limit of detection (LOD) as low as 73 ag/mL. This strategy proposed an avenue to synthesize highly efficient BMNCs-based ECL emitters, which have great potential in ultrasensitive biosensing for early diagnosis of diseases.
Keyphrases
- label free
- highly efficient
- sensitive detection
- loop mediated isothermal amplification
- quantum dots
- fluorescent probe
- gold nanoparticles
- single molecule
- cell free
- ionic liquid
- circulating tumor
- molecular dynamics simulations
- amino acid
- neuropathic pain
- molecularly imprinted
- transcription factor
- wastewater treatment
- metal organic framework
- high glucose
- fatty acid
- endothelial cells
- spinal cord injury
- mass spectrometry
- positron emission tomography
- lower limb
- low density lipoprotein